Back
Aardvark Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
AARD
Aardvark Therapeutics
Last Price:
$8.03
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and AARD is experiencing slight selling pressure.
Aardvark Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.5 | Sell |
| 20-day SMA: | 9.22 | Sell |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 8.6 | Sell |
| 20-day EMA: | 8.92 | Sell |
| 50-day EMA: | 7.35 | Buy |
| 200-day EMA: | 2.97 | Buy |
Aardvark Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 38.87 | Sell |
| Chaikin Money Flow: | -20173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.4 - 11) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
Aardvark Therapeutics Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aardvark Therapeutics Stock
Is Aardvark Therapeutics Stock a Buy?
-
Aardvark Therapeutics share price is 8.16 while AARD 8-day simple moving average is 8.50, which is a Sell signal.
-
The stock price of AARD is 8.16 while Aardvark Therapeutics 20-day SMA is 9.22, which makes it a Sell.
-
Aardvark Therapeutics 50-day simple moving average is 0.00 while AARD share price is 8.16, making it a Buy technically.
-
AARD stock price is 8.16 and Aardvark Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
AARD Technical Analysis vs Fundamental Analysis
Sell
11
Aardvark Therapeutics (AARD)
is a Sell
Is Aardvark Therapeutics a Buy or a Sell?
-
Aardvark Therapeutics stock is rated a SellThe current Aardvark Therapeutics [AARD] share price is $8.16. The Score for AARD is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Aardvark Therapeutics Stock Info
Market Cap:
174.2M
Price in USD:
8.16
Share Volume:
208.5K
Aardvark Therapeutics 52-Week Range
52-Week High:
19.58
52-Week Low:
6.79
Sell
11
Aardvark Therapeutics (AARD)
is a Sell
Aardvark Therapeutics Share Price Forecast
-
What is the Aardvark Therapeutics stock price today?The Aardvark Therapeutics stock price is 8.16 USD today.
-
Will AARD stock go up or go down?Aardvark Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Aardvark Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aardvark Therapeutics is overvalued.
Is Aardvark Therapeutics Stock a Buy?
-
Aardvark Therapeutics share price is 8.16 while AARD 8-day exponential moving average is 8.60, which is a Sell signal.
-
The stock price of AARD is 8.16 while Aardvark Therapeutics 20-day EMA is 8.92, which makes it a Sell.
-
Aardvark Therapeutics 50-day exponential moving average is 7.35 while AARD share price is 8.16, making it a Buy technically.
-
AARD stock price is 8.16 and Aardvark Therapeutics 200-day simple moving average is 2.97, creating a Buy signal.
Fundamental Analysis of Aardvark Therapeutics
Is Aardvark Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.42 per share, and an increase next year of $0.34 per share.
Technical Analysis of Aardvark Therapeutics
Should I short Aardvark Therapeutics stock?
-
AARD Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Aardvark Therapeutics is a Buy
-
Aardvark Therapeutics Relative Strength Index (RSI) is 38.87, which suggest Aardvark Therapeutics is oversold
-
The Bollinger Bands (25) for Aardvark Therapeutics is (8.4 - 11), which suggest Aardvark Therapeutics is a Buy
-
The Bollinger Bands (100) for Aardvark Therapeutics is ( - ), which suggest Aardvark Therapeutics is a Buy
* Aardvark Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.